Patent details
EP2773331 Title: FORMULATIONS FOR THE TREATMENT OF DIABETES
Basic Information
- Publication number:
- EP2773331
- PCT Application Number:
- PCT/US/2012/062816
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP127984706
- PCT Publication Number:
- WO/2013/067022
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- FORMULATIONS FOR THE TREATMENT OF DIABETES
- French Title of Invention:
- FORMULATIONS STABLES POUR INJECTION PARENTÉRALE DE MÉDICAMENTS PEPTIDIQUES
- German Title of Invention:
- FORMULIERUNGEN ZUR BEHANDLUNG VON DIABETES
- SPC Number:
Dates
- Filing date:
- 31/10/2012
- Grant date:
- 10/02/2016
- EP Publication Date:
- 10/02/2016
- PCT Publication Date:
- 10/05/2013
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 10/09/2014
- EP B1 Publication Date:
- 10/02/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 31/10/2016
- Expiration date:
- 31/10/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/10/2012
- Name:
- Xeris Pharmaceuticals Inc.
- Address:
- 3208 Red River, Suite 300, Austin TX 78705, United States (US)
Inventor
1
- Name:
- PRESTRELSKI Steven
- Address:
- United States (US)
2
- Name:
- SCOTT Nancy
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201161553388
- Priority Date:
- 31/10/2011
- Priority Country:
- United States (US)
2
- Priority Number:
- 201261609123
- Priority Date:
- 09/03/2012
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 9/00;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|